Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.
暂无分享,去创建一个
Y. Nakanuma | K. Itatsu | Y. Zen | Y. Nakanishi | S. Kondo | T. Itoh
[1] Y. Atomi,et al. Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria , 2007, Modern Pathology.
[2] Y. Nakanuma,et al. Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas , 2006, Hepatology.
[3] Y. Jan,et al. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases of hepatolithiasis. , 2006, Journal of hepatology.
[4] R. Hruban,et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study , 2005, Virchows Archiv.
[5] Y. Nimura,et al. Frequent p16ink4a inactivation is an early and frequent event of intraductal papillary neoplasm of the liver arising in hepatolithiasis. , 2004, Human pathology.
[6] J. Kench,et al. Pancreatic Intraepithelial Neoplasia in Association With Intraductal Papillary Mucinous Neoplasms of the Pancreas: Implications for Disease Progression and Recurrence , 2004, The American journal of surgical pathology.
[7] S. Batra,et al. Pathologic Features of Mucin-producing Bile Duct Tumors: Two Histopathologic Categories as Counterparts of Pancreatic Intraductal Papillary-mucinous Neoplasms , 2004, The American journal of surgical pathology.
[8] E. Furth,et al. Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract. , 2003, Human pathology.
[9] Motoko Sasaki,et al. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma. , 2003, Journal of hepato-biliary-pancreatic surgery.
[10] J. Kench,et al. Aberrant p16INK4A and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma , 2002, Gut.
[11] Y. Jan,et al. Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver. , 2002, Human pathology.
[12] J. Kench,et al. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia. , 2001, Cancer research.
[13] Y. Jan,et al. Intraductal papillary neoplasia of the liver associated with hepatolithiasis , 2001, Hepatology.
[14] G. Zamboni,et al. The Immunohistochemical Mucin Expression Pattern Distinguishes Different Types of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Determines Their Relationship to Mucinous Noncystic Carcinoma and Ductal Adenocarcinoma , 2001, The American journal of surgical pathology.
[15] R. Hruban,et al. Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts , 2001, Cancer.
[16] Y. Nakanuma,et al. Precancerous lesions of intrahepatic cholangiocarcinoma. , 2000, Journal of hepato-biliary-pancreatic surgery.
[17] J. Cameron,et al. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas. , 2000, The American journal of pathology.
[18] R. Hruban,et al. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. , 2000, Cancer research.
[19] W. Schmiegel,et al. Mutations of the DPC4/Smad4 gene in biliary tract carcinoma. , 1998, Cancer research.
[20] Y. Nakanuma,et al. Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply , 1997, Microscopy research and technique.
[21] C. Moskaluk,et al. Genomic Sequencing of DPC4 in the Analysis of Familial Pancreatic Carcinoma , 1997, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[22] C. Sherr. Cancer Cell Cycles , 1996, Science.
[23] J. Massagué,et al. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways , 1996, Nature.
[24] Kathleen R. Cho,et al. DPC4 gene in various tumor types. , 1996, Cancer research.
[25] Scott E. Kern,et al. DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.
[26] G. Hannon,et al. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA , 1994, Nature.
[27] J. Pines. p21 inhibits cyclin shock , 1994, Nature.
[28] Yi-Song Wang,et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. , 1994, Cancer research.
[29] G. Hannon,et al. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.
[30] Steven K. Hanks,et al. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins , 1992, Cell.
[31] A. Pardee. G1 events and regulation of cell proliferation. , 1989, Science.
[32] Y. Nakanuma,et al. Biliary papillary neoplasm of the liver. , 2002, Histology and histopathology.
[33] Cdm Fletcher,et al. World Health Organization Classification of Tumours , 2002 .
[34] A. Sparks,et al. Immunohistochemical labeling for Dpc4 mirrors genetic status in pancreatic adenocarcinomas: A new marker of DPC4 inactivation , 2000 .
[35] D. Longnecker. Intraductal papillary-mucinous neoplasms of the pancreas , 2000 .